← Leaderboards
Matthew Scott Alexander
University Of Alabama At Birmingham
$2,038,816
Attributed
$2,207,077
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $502K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,207,077 · 3
By mechanism
R01$1,633,988 · 1
R21$573,089 · 2
Top collaborators
- James J Dowling3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Thomas W Buford$9,083,841
- Qiang Ding$10,164,690
- Brant M Wagener$3,262,610
Others in their field
Other Emerging Leaders on “Duchenne Muscular Dystrophy”
- Amy Brower · American College Of Medical Genetics$8,744,067
- Courtney S Young · Myogene Bio, Llc$3,772,804
- Foteini Mourkioti · University Of Pennsylvania$3,480,431
- Melissa A.h. Witman · University Of Delaware$3,294,446
- Anthony D Saleh · Mirecule, Inc.$3,123,687
- Hongshuai Li · University Of Pittsburgh At Pittsburgh$2,775,048
Research focus
Duchenne Muscular DystrophyMouse ModelSignal PathwayPathogenesisLinkEvaluationSymptomsMusclePathologyGenesSeverity Of IllnessDisease ProgressionMediatingSerumBiological MarkersLoss Of Function MutationMicrornasGene ExpressionClinical TrialsOverexpressionPhenotypeBiopsyMyopathyProto-Oncogene Proteins C-Akt
Grant awards (9)
Dystrophin as a novel regulator of the circadian clock in skeletal muscle and the brain$236,566
R21 · FY2025 · NS · contact PI
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGY$325,118
R01 · FY2022 · HD · contact PI
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGY$328,750
R01 · FY2021 · HD · contact PI
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGY$318,324
R01 · FY2020 · HD · contact PI
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGY$318,132
R01 · FY2019 · HD · contact PI
Micro RNAs as biomarkers and therapeutic targets in myotubular myopathy$158,214
R21 · FY2019 · AR
Micro RNAs as biomarkers and therapeutic targets in myotubular myopathy$20,000
R21 · FY2019 · AR
A MIR-486/DOCK3 SIGNALING AXIS MODULATES DYSTROPHIN-DEFICIENT PATHOLOGY$343,664
R01 · FY2018 · HD · contact PI
Micro RNAs as biomarkers and therapeutic targets in myotubular myopathy$158,309
R21 · FY2018 · AR